IFF restructuring
This article was originally published in The Rose Sheet
Executive Summary
International Flavors & Fragrances will cut approximately 300 jobs, or 6% of its workforce, mainly in manufacturing, selling, research and administration functions in its European and North American operating regions, firm announces Jan. 10. Initiative will result in pre-tax restructuring charges of $25 mil.-$30 mil., most of which will be recognized in the fourth quarter, IFF says. "These actions are a necessary part of our ongoing efforts to maintain and improve IFF's profitability in the economic environment in which we operate," according to IFF CEO Richard Goldstein. Firm anticipates 2005 sales to be down 2%, impacted by the divestiture of its European fruit preparations business in 2004, IFF states. Company expects to release 2005 Q4 and full year earnings Jan. 25...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.